No longer trading
Delisted
The delisting was filed on March 2, 2026 (SEC Form 15-12G). Its last closing price was on March 20, 2026. It has left the AI-ranked universe. The score and rank below are its final ones, from March 2, 2026. Source: SEC Form 15-12G
Final 13F Pro quality score
Final rank #2,588 of 2,753 · as of March 2, 2026
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from STRATA Skin Sciences, Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $30.7M | $-6.3M | -15.3% |
| FY 2024 | 10-K | $33.6M | $-10.1M | -27.6% |
| FY 2023 | 10-K | $33.4M | $-10.8M | -25.8% |
| FY 2022 | 10-K | $36.2M | $-5.5M | -12.9% |
| FY 2021 | 10-K | $30.0M | $-2.7M | -14.7% |
| FY 2020 | 10-K | $23.1M | $-4.4M | -17.6% |
Delisted: STRATA Skin Sciences, Inc. (SSKN) no longer trades and has left 13F Pro's AI-ranked universe. The delisting was filed on March 2, 2026 (SEC Form 15-12G). Its last closing price was on March 20, 2026. It has left the AI-ranked universe. The score and rank below are its final ones, from March 2, 2026. STRATA Skin Sciences, Inc. (SSKN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro tracks SSKN using direct SEC EDGAR data and AI-powered research tools. Based on the latest XBRL financial filings (Q4 2025), STRATA Skin Sciences, Inc. reports quarterly revenue of $9.3M, net income of $58.0K, an operating margin of 5.3%. SSKN trades on the Nasdaq exchange and files with the SEC under CIK 1051514. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SSKN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for STRATA Skin Sciences, Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1051514 →